Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Studies Point to Many Benefits of Weightbearing CT Scanning Technology

For patients whose lives are impacted by medical technology breakthroughs, there is a significant improvement in the quality of care their doctors are then able to provide. This is especially true when it comes to cone beam computed tomography (CT) scanning. In the last decade, the innovations made in this field have allowed for true…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

For patients whose lives are impacted by medical technology breakthroughs, there is a significant improvement in the quality of care their doctors are then able to provide. This is especially true when it comes to cone beam computed tomography (CT) scanning. In the last decade, the innovations made in this field have allowed for true weightbearing CT scans to be taken.

In order to present a picture of the difference weightbearing CT scanning has made on foot and ankle patients, authors from the University of Utah, as well as a team of international researchers, presented a series of studies showing the benefits of the new technology. In their article, Weightbearing Computed Topography of the Foot and Ankle: Emerging Technology Topical ReviewDrs. Alexej Barg and Charles Saltzman show that true weightbearing CT scans are far more effective than their simulated counterparts.

The article covered 8 studies performed between 2013 and 2017, each of which covered alignment analysis within the foot. While previous attempts to replicate weightbearing environments involved rigging up weights to affect the foot while the patient was lying down, modern technology is allowing doctors to observe the interactions within the foot in actual weightbearing scenarios with the patient standing and even walking. Regardless of whether the studies focused on talar anatomy, hindfoot alignment, valgus deformities or flat-footedness, the studies all had a similar theme. The cone beam weightbearing CT scan offered a more complete view of the relationships in the foot than what was attainable with traditional radiography.

Perhaps most importantly, the overview of the literature available pointed to several key benefits offered by this scanning technology. Not only does it allow for scans to be taken while the patient is standing, but there is increased spatial resolution and faster imaging times due to cone beam scanning. Plus, the side benefits of having lower radiation than traditional CT scans coupled with modest costs can help alleviate many patient concerns. The authors also advocate for utilizing the images provided through weightbearing CT scanning to establish standardized forefoot, midfoot and hindfoot alignment positions using anatomical landmarks, which could greatly enhance both diagnoses and care plan development for the patient.

Leading the charge in this innovative technology is CurveBeam. With a line of cone beam scanning devices like the InReach, LineUP and their standard PedCAT, CurveBeam allows clinics to offer weight bearing CT scanning to their patients to improve their quality of care. To learn more about the possibilities offered by devices like the PedCAT, or to see their products for yourself, visit http://www.curvebeam.com/products/pedcat/ today!

Read more at curvebeam.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512